Search

everythinglearnresearchcommunity

for

Search:↓

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Brodalumab is more effective than ustekinumab for treating psoriasis.

cGEL hydrogel improves melanin production in skin cells, making it a promising option for skin treatments.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Baricitinib may effectively treat lichen planopilaris.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.

Abrocitinib may effectively treat stubborn alopecia universalis.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Applying pseudoceramide improved skin and hair health.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Peimine helps heal skin wounds by activating a specific cell signaling pathway.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

New cytokine-targeted therapies show promise for treating alopecia areata.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Enhancing Tregs can protect against alopecia areata.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The patch effectively promotes hair growth for alopecia areata without pain.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.